Robin Shivnaraine, PhD, Director of Clinical Pharmacology at Aerys Biosciences, will attend the J.P. Morgan Healthcare Conference, January 12–15, 2026, in San Francisco, California.Dr. Shivnaraine is seeking meetings with clinical development partners and funding organizations interested in collaborating on programs for idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH).